Get the Weekly Intelligence Brief — top committee picks every Sunday.

ACA vs HUBB

Arcosa, Inc. vs Hubbell Incorporated — AI-powered side-by-side comparison
ACA
Arcosa, Inc.
65
Buy
VS
HUBB
Hubbell Incorporated
72
Buy
MetricACAHUBB
AI Score 65 72
Price $144.97 $519.42
P/E Ratio 14.49× 30.66×
ROE 7.9% 23.1%
Revenue Growth YoY
Gross Margin 23.0% 35.2%
Debt / Equity 0.48× 1.37×
Dividend Yield 0.1% 1.1%
RSI (14) 51.0 57.9
Beta 1.071 0.898
Expected Upside +5.7%

AI Committee View

Current Innellis committee reasoning for ACA versus HUBB.
HUBB leads by 7 points.

HUBB scores 72/100 (Buy) versus ACA at 65/100 (Buy).

ACA Committee View
83% agreement
6 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is news sentiment is negative (-0.33 across 3 articles, 14d). The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 14.5 is inexpensive for the broad market — Value
  • ROE of 18.1% shows genuine earnings power backing the valuation — Value
  • EPS growing 431.7% YoY — Growth
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • News sentiment is negative (-0.33 across 3 articles, 14d) — News
HUBB Committee View
100% agreement
4 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ACA Full Analysis HUBB Full Analysis